U.S. Markets closed

HanAll Biopharma Co., Ltd. (009420.KS)

KSE - KSE Delayed Price. Currency in KRW
Add to watchlist
13,750.00+50.00 (+0.36%)
At close: 3:30PM KST
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue82,882,00080,023,00080,880,00074,228,000
Cost of Revenue44,494,00043,512,00040,997,00042,680,000
Gross Profit38,388,00036,510,00039,883,00031,548,000
Operating Expenses
Research Development----
Selling General and Administrative----
Non Recurring----
Total Operating Expenses82,596,00084,303,00080,064,00087,211,000
Operating Income or Loss285,000-4,280,000815,000-12,983,000
Income from Continuing Operations
Total Other Income/Expenses Net----
Earnings Before Interest and Taxes285,000-4,280,000815,000-12,983,000
Interest Expense--680,000-989,000-1,374,000
Income Before Tax----
Income Tax Expense-352,0002,252,000-99,000919,000
Minority Interest----
Net Income From Continuing Ops----
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income2,026,000-7,077,000-12,658,000-21,499,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares----